日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IUC24415-81 Clinical outcomes in stage I seminoma patients aged ≥ 45 years according to treatment modality

IUC24415-81 45岁及以上I期精原细胞瘤患者的临床结局(按治疗方式划分)

Kao, Grace S; Xu, Wenxin (Vincent); Xie, Wanling; Liu, Fuguo; Birch, Grace; Welch, Casey; Nguyen, Maily; Stanojevic, Mila; Viswanathan, Srinivas; McGregor, Bradley A; Ritz, Jerome; Braun, David; Nikiforow, Sarah; Romee, Rizwan; Choueri, Toni; Tang, Yan; Han, Tiegang; Mansour, Hadi; Hirsch, Michelle S; Collins, Katrina; Henske, Elizabeth P; Tang, Cerise; Poduval, Deepak; Rout, Rishabh; Lee, Suzanna; Panian, Justine; Saidian, Ava; McKay, Rana; Braun, David; Wilde, Blake; Christofk, Heather R; Bari, Shahla; Darwin, Alicia; Sarfraz, Humaira; Singh, Tarundeep; Muzaffar, Noha; Muzaffar, Jameel; Neola, G; Maruzzo, M; Maffezzoli, M; Rizzo, M; Scagliarini, S; Danielli, L; Conteduca, V; Giannatempo, P; Maiorano, B A; Formisano, L; Banna, G; Maniam, A; Rescigno, P; Reid, A; Crabb, S; Maffezzoli, M; Smalley, B; Redla, A C; Mehrotra, S; Tan, J K; Ghose, A; Shah, A; Kotecha, P; Sharma, A; Das, P; Teoh, J; Vasdev, N; Mascaro, F; Marmiroli, A; Nuzzo, A; Maruzzo, M; Bimbatti, D; Nazzani, S; Claps, M; Procopio, G; Nicolai, N; Giannatempo, P

IUC24428-85 Real-world effectiveness of ipilimumab plus nivolumab in second-line in patients with metastatic clear cell renal cell carcinoma (mccRCC) based on prior receipt of PD-1/L1 inhibitors

IUC24428-85 基于既往接受过 PD-1/L1 抑制剂治疗的转移性透明细胞肾细胞癌 (mccRCC) 患者二线治疗中,ipilimumab 联合 nivolumab 的真实世界疗效

Einarsdottir, Sigrun; Andersson, Per-Ola; Ayanambakkam, Adanma; McKay, Rana; Basu, Arnab; Maughan, Benjamin; Plets, Melissa; Pal, Sumanta; Ged, Yasser; Tangen, Cathryn; Vaishampayan, Ulka; Lerner, Seth; Desai, Arpita; Xie, Bingqing; Mishra, Akhilesh; Gao, Ming; Brugarolas, James; Rittenhouse, Nicole; Nargund Mangalvedhekar, Amrita; Zaidi, Samir; Hakimi, A Ari; Dere, Ruhee; Motrapu, Manga; Boice, Ashley; Han, Richard; Wang, Xiaoli; Chowdhury, Pratim; Jung, Sung; Prasad, B V Venkata; McGregor, Bradley A; Murgic, J; Jazvic, M; Tomaskovic, I; Bokarica, P; Gamulin, M; Dilber, I; Penc, M Sambic; Zahirovic, D; Omrcen, T; Frobe, A; Bimbatti, D; Messina, C; Bonomi, L; Scagliarini, S; Chiellino, S; Maiorano, B A; Deppieri, F M; Cavo, A; Conteduca, V; Rebuzzi, S E; Rebuzzi, S E; Messina, C; Bonomi, L; Scagliarini, S; Chiellino, S; Maiorano, B A; Deppieri, F M; Cavo, A; Conteduca, V; Bimbatti, D; Richert, Julia; Wenta, Robert; Muchlińska, Anna; Pieczyńska-Uziębło, Beata; Żaczek, Anna; Miszewski, Kevin; Matuszewski, Marcin; Bednarz-Knoll, Natalia; Ozay, Z I; Jo, Y; Ostrowski, M; Sayegh, N; Graf, R; Roy, S; Antonarakis, E; McKay, R; Agarwal, N; Swami, U; Maffezzoli, M; Pedapati, L; Hassan, M; Sandulache, S A; Samuel, J; Costanzo, F Di; Neola, G; Lau, J; Maniam, A; Banna, G; Mehrotra, S; Redla, A C; Tan, J K; Ghose, A; Maniam, A; Boussios, S; Banna, G L; Das, P; Adeleke, S; Sharma, A; Aggarwal, P; Satapathy, S; Sood, A; Goyal, S; Prakash, G; Mittal, B R; Ozay, Z I; Jo, Y; Gebrael, G; Ostrowski, M; Murdock, E; Jamie-Casas, S; Zugman, M; Agarwal, N; Pal, S; Swami, U

Prediction of mode of delivery by an ultrasound score similar to Bishop score and performance of independent predictors

利用类似于Bishop评分的超声评分预测分娩方式以及独立预测因子的性能

Manchu, Madhuri; Redla, Vidyarama

Bilateral adrenal haemorrhage with renal infarction after ChAdOx1 nCoV-19 AstraZeneca vaccination

接种阿斯利康 ChAdOx1 nCoV-19 疫苗后出现双侧肾上腺出血伴肾梗死

Tha, Tun; Martini, Iana; Stefan, Elena; Redla, Sridhar

Incidental pulmonary embolism in oncology patients with current macroscopic malignancy: incidence in different tumour type and impact of delayed treatment on survival outcome

肿瘤患者(目前患有肉眼可见的恶性肿瘤)发生偶发性肺栓塞:不同肿瘤类型的发病率及延迟治疗对生存结局的影响

Myat Moe, Maung Maung; Redla, Sridhar